中等立体定向剂量放疗与免疫检查点阻断诱导的复极化巨噬细胞有助于胶质瘤小鼠长期生存
研究在胶质瘤异种移植小鼠中比较无治疗、单纯放疗、单纯抗PD-1抗体及放疗联合抗PD-1的疗效。联合治疗组达75%完全病理缓解并显著改善生存,CD8+ T细胞与巨噬细胞均为联合治疗全效应所必需,放疗可触发巨噬细胞复极化并提高M1/M2比值。
要点
- 联合治疗组达75%完全病理缓解并显著改善生存。
- CD8+ T细胞与巨噬细胞均为联合治疗全效应所必需。
- 放疗触发巨噬细胞复极化,提高M1/M2比值。
核心结论
- 联合治疗通过CD8+ T细胞早期作用与巨噬细胞后期介导的免疫机制发挥作用。
- 结果为免疫原性剂量放疗联合免疫检查点阻断用于新诊断高级别胶质瘤的临床研究提供基础。
研究设计与样本
- 胶质瘤异种移植荷瘤小鼠随机分为无治疗、单纯放疗、单纯抗PD-1、放疗联合抗PD-1四组。
- 放疗为脑定向高剂量照射(单次10 Gy),联合小鼠抗PD-1抗体。
- 采用MRI监测肿瘤生长并随访生存,用免疫组化、基因表达芯片和流式细胞术分析治疗效应。
- 使用T淋巴细胞、骨髓来源巨噬细胞和小胶质细胞的药理学抑制剂评估各免疫群作用。
主要发现
- 联合治疗组达75%完全病理缓解并显著改善生存。
- CD8+ T细胞和巨噬细胞均为联合治疗全效应所必需,T淋巴细胞似乎在早期发挥作用,巨噬细胞介导联合治疗效应的后期阶段。
- 放疗似乎触发巨噬细胞复极化,提高M1/M2比值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Glioblastoma multiforme (GBM) is a deadly brain tumor with a short expected median survival, despite current standard-of-care treatment. We explored the combination of intermediate stereotactic dose radiation therapy and immune checkpoint inhibitor therapy as a novel treatment strategy for GBM. METHODS: Glioma xenograft-bearing mice were exposed to high dose brain-directed radiation (10 Gy single exposure) as well as mouse anti-PD-1 antibody. The tumor-bearing animals were randomized to four groups: no treatment, radiation alone, anti-PD-1 alone, and radiation + anti-PD-1. Survival was followed, and tumor growth was monitored using MRI. Immunohistochemistry, gene expression arrays, and flow cytometry were used to characterize the treatment-induced effects. Pharmacologic inhibitors of T-lymphocytes, bone marrow derived macrophages, and microglia were used to assess the respective roles of different immune populations in observed treatment effects. RESULTS: We found the combined treatment with high dose radiation and immunotherapy to be highly effective with a 75% complete pathologic response and dramatically improved survival outcomes. We found both CD8+ T-cells and macrophages to be necessary for the full effect of combined therapy, with T lymphocytes appearing to play a role early on and macrophages mediating a later phase of the combined treatment effect. Radiation treatment appeared to trigger macrophage repolarization, increasing M1/M2 ratio. CONCLUSIONS: These findings point to a novel immunologic mechanism underlying the interaction between radiotherapy and immunotherapy. They also provide the basis for clinical investigation of immunogenic dose radiation in combination with immune checkpoint blockade as a potential treatment approach for newly diagnosed high grade gliomas.
引用
- Stessin AM, Clausi MG, Zhao Z, et al. Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice. J Neurooncol. 2020. PMID: 32215786. doi:10.1007/s11060-020-03459-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。